Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2872143 | The Annals of Thoracic Surgery | 2014 | 9 Pages |
Abstract
Cardiac surgical patients often have associated comorbidities that can impede normal wound healing; however, statin therapy has the potential to improve this process through augmentation of the normal inflammatory response. Outcomes included a 30% earlier rate of wound epithelialization and an 80% greater wound-breaking strength combined with faster wound healing rates (13.0 days vs 18.7 days, p < 0.0001). Inhibition of farnesyl pyrophosphate may hold a key role in the mediation of such advantageous effects. This systematic review suggests that there is sufficient evidence to warrant completion of a human trial to assess the effects of statins on wound healing.
Keywords
EGFIGFKGFPDGFFPPbFGFHMG-CoAeNOSIFN-γTGF3-hydroxy-3-methylglutaryl-coenzyme Ainterferon-γinterleukintransforming growth factorendothelial nitric oxide synthaseepidermal growth factorKeratinocyte growth factorfarnesyl pyrophosphateVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)platelet-derived growth factorInsulin-like growth factorNitric oxide
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Gerard J. MRCSI, MS, Billy MS, Lars FRCS (CTh), J. Mark MD, FRCS (CTh), Jonathan G. PhD, FRCS (CTh), Mark E. MD, FRCS,